• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Graft-host coupling changes can lead to engraftment arrhythmia: a computational study.移植物-宿主耦合变化可导致植入心律失常:计算研究。
J Physiol. 2023 Jul;601(13):2733-2749. doi: 10.1113/JP284244. Epub 2023 Apr 25.
2
Modelling the interaction between stem cells derived cardiomyocytes patches and host myocardium to aid non-arrhythmic engineered heart tissue design.为了辅助非心律失常性工程心脏组织设计,对来源于干细胞的心肌细胞片与宿主心肌之间的相互作用进行建模。
PLoS Comput Biol. 2022 Apr 1;18(4):e1010030. doi: 10.1371/journal.pcbi.1010030. eCollection 2022 Apr.
3
Assessing the arrhythmogenic risk of engineered heart tissue patches through in silico application on infarcted ventricle models.通过在梗死心室模型上的计算机模拟应用评估工程心脏组织贴片的致心律失常风险。
Comput Biol Med. 2023 Mar;154:106550. doi: 10.1016/j.compbiomed.2023.106550. Epub 2023 Jan 13.
4
Pluripotent stem cell-based cardiac regenerative therapy for heart failure.基于多能干细胞的心力衰竭心脏再生疗法。
J Mol Cell Cardiol. 2024 Feb;187:90-100. doi: 10.1016/j.yjmcc.2023.12.001. Epub 2024 Feb 6.
5
Cardiomyocytes from CCND2-overexpressing human induced-pluripotent stem cells repopulate the myocardial scar in mice: A 6-month study.CCND2 过表达的人诱导多能干细胞来源的心肌细胞在小鼠心肌瘢痕中再定植:一项 6 个月的研究。
J Mol Cell Cardiol. 2019 Dec;137:25-33. doi: 10.1016/j.yjmcc.2019.09.011. Epub 2019 Oct 17.
6
Cardiac muscle patches containing four types of cardiac cells derived from human pluripotent stem cells improve recovery from cardiac injury in mice.人心肌细胞贴片包含四种源自人类多能干细胞的人心肌细胞,可改善小鼠的心脏损伤恢复。
Cardiovasc Res. 2023 May 2;119(4):1062-1076. doi: 10.1093/cvr/cvad004.
7
Expandable human cardiovascular progenitors from stem cells for regenerating mouse heart after myocardial infarction.从干细胞中扩增的人类心血管祖细胞可用于心肌梗死后再生小鼠心脏。
Cardiovasc Res. 2020 Mar 1;116(3):545-553. doi: 10.1093/cvr/cvz181.
8
Gene editing to prevent ventricular arrhythmias associated with cardiomyocyte cell therapy.基因编辑预防与心肌细胞治疗相关的室性心律失常。
Cell Stem Cell. 2023 Apr 6;30(4):396-414.e9. doi: 10.1016/j.stem.2023.03.010.
9
Assessment of arrhythmia mechanism and burden of the infarcted ventricles following remuscularization with pluripotent stem cell-derived cardiomyocyte patches using patient-derived models.使用患者来源模型评估多能干细胞衍生的心肌细胞贴片再肌化后梗死心室的心律失常机制和负荷。
Cardiovasc Res. 2022 Mar 25;118(5):1247-1261. doi: 10.1093/cvr/cvab140.
10
Large Cardiac Muscle Patches Engineered From Human Induced-Pluripotent Stem Cell-Derived Cardiac Cells Improve Recovery From Myocardial Infarction in Swine.由人诱导多能干细胞衍生的心肌细胞构建的大型心肌斑块可改善猪心肌梗死后的恢复。
Circulation. 2018 Apr 17;137(16):1712-1730. doi: 10.1161/CIRCULATIONAHA.117.030785. Epub 2017 Dec 12.

引用本文的文献

1
Unique Challenges in myocardial regeneration and the hidden potentials of resident cardiac macrophages.心肌再生中的独特挑战与心脏驻留巨噬细胞的隐藏潜力
J Stem Cells Regen Med. 2025 May 29;21(1):1-2. doi: 10.46582/jsrm.2101001. eCollection 2025.
2
Computational Simulations Show Proof-of-Concept for Optogenetic Suppression of Ectopic Activity in Cardiac Stem Cell Therapy.计算机模拟显示了光遗传学抑制心脏干细胞治疗中异位活动的概念验证。
Cardiovasc Eng Technol. 2025 Jul 16. doi: 10.1007/s13239-025-00794-x.
3
Pluripotent stem cell-derived cardiomyocyte transplantation: marching from bench to bedside.多能干细胞衍生的心肌细胞移植:从实验台走向临床应用。
Sci China Life Sci. 2025 May 23. doi: 10.1007/s11427-024-2801-x.
4
Population-based computational simulations elucidate mechanisms of focal arrhythmia following stem cell injection.基于人群的计算模拟阐明了干细胞注射后局灶性心律失常的机制。
J Mol Cell Cardiol. 2025 Jul;204:5-16. doi: 10.1016/j.yjmcc.2025.04.010. Epub 2025 Apr 23.
5
Bridging the Gap: Advances and Challenges in Heart Regeneration from In Vitro to In Vivo Applications.弥合差距:从体外到体内应用的心脏再生研究进展与挑战
Bioengineering (Basel). 2024 Sep 24;11(10):954. doi: 10.3390/bioengineering11100954.
6
In silico evaluation of cell therapy in acute versus chronic infarction: role of automaticity, heterogeneity and Purkinje in human.急性与慢性梗死中细胞治疗的计算机模拟评估:自律性、异质性和浦肯野纤维在人体中的作用
Sci Rep. 2024 Sep 16;14(1):21584. doi: 10.1038/s41598-024-67951-5.
7
Casein Kinase 1 Phosphomimetic Mutations Negatively Impact Connexin-43 Gap Junctions in Human Pluripotent Stem Cell-Derived Cardiomyocytes.酪蛋白激酶 1 磷酸模拟突变负性影响人多能干细胞源性心肌细胞缝隙连接蛋白 43 连接。
Biomolecules. 2024 Jan 2;14(1):61. doi: 10.3390/biom14010061.
8
Cell diversity and signalling in the cardiovascular system.心血管系统中的细胞多样性与信号传导
J Physiol. 2023 Jul;601(13):2537-2539. doi: 10.1113/JP284979. Epub 2023 May 27.

本文引用的文献

1
Modelling the interaction between stem cells derived cardiomyocytes patches and host myocardium to aid non-arrhythmic engineered heart tissue design.为了辅助非心律失常性工程心脏组织设计,对来源于干细胞的心肌细胞片与宿主心肌之间的相互作用进行建模。
PLoS Comput Biol. 2022 Apr 1;18(4):e1010030. doi: 10.1371/journal.pcbi.1010030. eCollection 2022 Apr.
2
OPTN/SRTR 2020 Annual Data Report: Heart.OPTN/SRTR 2020 年度数据报告:心脏。
Am J Transplant. 2022 Mar;22 Suppl 2:350-437. doi: 10.1111/ajt.16977.
3
In Vitro Matured Human Pluripotent Stem Cell-Derived Cardiomyocytes Form Grafts With Enhanced Structure and Function in Injured Hearts.体外成熟的人多能干细胞衍生心肌细胞在受损心脏中形成具有增强结构和功能的移植物。
Circulation. 2022 May 3;145(18):1412-1426. doi: 10.1161/CIRCULATIONAHA.121.053563. Epub 2022 Jan 28.
4
Personalized computational heart models with T1-mapped fibrotic remodeling predict sudden death risk in patients with hypertrophic cardiomyopathy.基于 T1 mapping 纤维化重构的个体化计算心脏模型预测肥厚型心肌病患者猝死风险。
Elife. 2022 Jan 25;11:e73325. doi: 10.7554/eLife.73325.
5
Optogenetic Stimulation Using Anion Channelrhodopsin (GtACR1) Facilitates Termination of Reentrant Arrhythmias With Low Light Energy Requirements: A Computational Study.使用阴离子通道视紫红质(GtACR1)的光遗传学刺激以低光能量需求促进折返性心律失常的终止:一项计算研究。
Front Physiol. 2021 Aug 30;12:718622. doi: 10.3389/fphys.2021.718622. eCollection 2021.
6
Pharmacologic therapy for engraftment arrhythmia induced by transplantation of human cardiomyocytes.人源心肌细胞移植所致移植心律失常的药物治疗。
Stem Cell Reports. 2021 Oct 12;16(10):2473-2487. doi: 10.1016/j.stemcr.2021.08.005. Epub 2021 Sep 9.
7
Computational modeling of aberrant electrical activity following remuscularization with intramyocardially injected pluripotent stem cell-derived cardiomyocytes.心肌内注射多能干细胞源性心肌细胞后异常电活动的计算建模。
J Mol Cell Cardiol. 2022 Jan;162:97-109. doi: 10.1016/j.yjmcc.2021.08.011. Epub 2021 Sep 3.
8
The openCARP simulation environment for cardiac electrophysiology.openCARP 心脏电生理模拟环境。
Comput Methods Programs Biomed. 2021 Sep;208:106223. doi: 10.1016/j.cmpb.2021.106223. Epub 2021 Jun 8.
9
Computational modeling identifies embolic stroke of undetermined source patients with potential arrhythmic substrate.计算模型确定潜在心律失常基质的不明来源栓塞性卒中患者。
Elife. 2021 May 4;10:e64213. doi: 10.7554/eLife.64213.
10
Assessment of arrhythmia mechanism and burden of the infarcted ventricles following remuscularization with pluripotent stem cell-derived cardiomyocyte patches using patient-derived models.使用患者来源模型评估多能干细胞衍生的心肌细胞贴片再肌化后梗死心室的心律失常机制和负荷。
Cardiovasc Res. 2022 Mar 25;118(5):1247-1261. doi: 10.1093/cvr/cvab140.

移植物-宿主耦合变化可导致植入心律失常:计算研究。

Graft-host coupling changes can lead to engraftment arrhythmia: a computational study.

机构信息

Department of Bioengineering, University of Washington, Seattle, WA, USA.

Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA, USA.

出版信息

J Physiol. 2023 Jul;601(13):2733-2749. doi: 10.1113/JP284244. Epub 2023 Apr 25.

DOI:10.1113/JP284244
PMID:37014103
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10901678/
Abstract

After myocardial infarction (MI), a significant portion of heart muscle is replaced with scar tissue, progressively leading to heart failure. Human pluripotent stem cell-derived cardiomyocytes (hPSC-CM) offer a promising option for improving cardiac function after MI. However, hPSC-CM transplantation can lead to engraftment arrhythmia (EA). EA is a transient phenomenon arising shortly after transplantation then spontaneously resolving after a few weeks. The underlying mechanism of EA is unknown. We hypothesize that EA may be explained partially by time-varying, spatially heterogeneous, graft-host electrical coupling. Here, we created computational slice models derived from histological images that reflect different configuration of grafts in the infarcted ventricle. We ran simulations with varying degrees of connection imposed upon the graft-host perimeter to assess how heterogeneous electrical coupling affected EA with non-conductive scar, slow-conducting scar and scar replaced by host myocardium. We also quantified the effect of variation in intrinsic graft conductivity. Susceptibility to EA initially increased and subsequently decreased with increasing graft-host coupling, suggesting the waxing and waning of EA is regulated by progressive increases in graft-host coupling. Different spatial distributions of graft, host and scar yielded markedly different susceptibility curves. Computationally replacing non-conductive scar with host myocardium or slow-conducting scar, and increasing intrinsic graft conductivity both demonstrated potential means to blunt EA vulnerability. These data show how graft location, especially relative to scar, along with its dynamic electrical coupling to host, can influence EA burden; moreover, they offer a rational base for further studies aimed to define the optimal delivery of hPSC-CM injection. KEY POINTS: Human pluripotent stem cell-derived cardiomyocytes (hPSC-CM) hold great cardiac regenerative potential but can also cause engraftment arrhythmias (EA). Spatiotemporal evolution in the pattern of electrical coupling between injected hPSC-CMs and surrounding host myocardium may explain the dynamics of EA observed in large animal models. We conducted simulations in histology-derived 2D slice computational models to assess the effects of heterogeneous graft-host electrical coupling on EA propensity, with or without scar tissue. Our findings suggest spatiotemporally heterogeneous graft-host coupling can create an electrophysiological milieu that favours graft-initiated host excitation, a surrogate metric of EA susceptibility. Removing scar from our models reduced but did not abolish the propensity for this phenomenon. Conversely, reduced intra-graft electrical connectedness increased the incidence of graft-initiated host excitation. The computational framework created for this study can be used to generate new hypotheses, targeted delivery of hPSC-CMs.

摘要

心肌梗死后(MI),大量心肌被瘢痕组织取代,逐渐导致心力衰竭。人类多能干细胞衍生的心肌细胞(hPSC-CM)为改善 MI 后心功能提供了一种很有前途的选择。然而,hPSC-CM 移植可导致植入性心律失常(EA)。EA 是移植后不久出现的短暂现象,数周后自发消退。EA 的潜在机制尚不清楚。我们假设 EA 部分可以通过时间变化的、空间异质的、移植物-宿主电偶联来解释。在这里,我们创建了源自组织学图像的计算切片模型,这些模型反映了梗死心室中移植物的不同构型。我们通过对移植物-宿主周界施加不同程度的连接来运行模拟,以评估异质电偶联如何影响无导电瘢痕、慢传导瘢痕和被宿主心肌替代的瘢痕中的 EA。我们还量化了移植物固有导电性变化的影响。随着移植物-宿主耦合的增加,EA 的易感性最初增加,随后降低,这表明 EA 的消长受到移植物-宿主耦合的逐渐增加的调节。移植物、宿主和瘢痕的不同空间分布产生了明显不同的易感性曲线。用宿主心肌或慢传导瘢痕替代无导电瘢痕,以及增加移植物固有导电性,均显示出减弱 EA 易感性的潜在手段。这些数据表明移植物的位置,特别是相对于瘢痕的位置,以及与宿主的动态电偶联,如何影响 EA 负担;此外,它们为进一步研究定义 hPSC-CM 注射的最佳递送提供了合理的基础。要点:人类多能干细胞衍生的心肌细胞(hPSC-CM)具有很大的心脏再生潜力,但也会引起植入性心律失常(EA)。注入的 hPSC-CM 与周围宿主心肌之间电偶联模式的时空演变可能解释了在大动物模型中观察到的 EA 动态。我们在组织学衍生的 2D 切片计算模型中进行了模拟,以评估不均匀的移植物-宿主电偶联对 EA 倾向的影响,有无瘢痕组织。我们的研究结果表明,时空不均匀的移植物-宿主偶联可以产生有利于移植物引发宿主兴奋的电生理环境,这是 EA 易感性的替代指标。从我们的模型中去除瘢痕组织减少了但没有消除这种现象的发生。相反,降低移植物内的电连接性会增加移植物引发的宿主兴奋的发生率。本研究创建的计算框架可用于产生新的假设,有针对性地递送 hPSC-CM。